The soluble antigens of GBS as human vaccines.
D000818:Animals; D000831:Animals, Newborn; D016667:Bacterial Capsules; D001428:Bacterial Vaccines / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009895:Opsonin Proteins; D011135:Polysaccharides, Bacterial / Q000276:immunology*; D051381:Rats; D013290:Streptococcal Infections / Q000517:prevention & control; D013292:Streptococcus agalactiae / Q000276:immunology*
D001428:Bacterial Vaccines; D009895:Opsonin Proteins; D011135:Polysaccharides, Bacterial; C038687:capsular polysaccharide, streptococcal group B type II; C032263:streptococcal polysaccharide type III group B; C037678:streptococcal polysaccharide Ia group B